Table 4 Characteristics of retrospective longitudinal study of Study 3 followed from a hospital admission in 2012 until death or censorship in 2017, stratified by IDCR < 0.05 at any time during follow up

Number of patients, n

39

23

16

Age, mean ± SD, years

66 ± 14

68 ± 13

64 ± 16

Women, n (%)

22 (56)

12 (52)

10 (62)

 White

21 (54)

13 (57)

8 (50)

 Black

9 (23)

6 (26)

3 (19)

 Hispanic

6 (15)

3 (13)

3 (19)

 Asian

3 (8)

1 (4)

2 (12)

Years on hemodialysis at start of follow-up, mean ± SD

1.8 ± 0.5

1.9 ± 0.6

1.6 ± 0.5

Presence of CAD or PAD^c, n (%)

20 (51)

9 (39)

11 (69)

LVEF^c < 40%, n (%)

6 (15)

2 (9)

4 (25)

Number of deaths during follow-up, n (%)

21 (54)

18 (78)

3 (19)

Median survival, days

1126

32^b

Not calculated^a